Longtime Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics
The COO of Seattle Genetics, Eric Dobmeier, is leaving the company to helm Silverback Therapeutics. Source: BioSpace
The COO of Seattle Genetics, Eric Dobmeier, is leaving the company to helm Silverback Therapeutics. Source: BioSpace
There are some changes taking place in the C-suites at Shire. Source: BioSpace
HeartFlow makes software that builds a 3D model of your heart’s arteries, based on CT scans. Source: BioSpace
Foundation Medicine's sequencing diagnostics test for solid tumors that can detect cancer-causing mutations in 324 genes was approved by the FDA Thursday. Source: BioSpace
The spike began after the six-person company announced it had entered into a multi-year services agreement with Merck KGaA. Source: BioSpace
An IDMC told Bayer that it should unblind its Phase III clinical trial in prostate cancer in order to further analyze an increased number of fractures and deaths. Source: BioSpace
These great biotech stocks to buy for the holidays come in all sizes -- small-cap, mid-cap, and large-cap. Source: BioSpace
Speculation has increased that Amazon might enter the pharmacy market after it conducted high-level talks with generic drug companies Mylan and Sandoz, a division of Novartis. Source: BioSpace
The primary endpoint of brain atrophy as defined by PBVC from baseline to week 48, was not met after daily oral doses with 0.6 mg laquinimod. Source: BioSpace
Basilea eligible to receive additional upfront and milestone payments of up to USD 226 million and mid-teen royalties on sales. Source: BioSpace